Diagnostic Challenges of ESA-Resistant Anemia with MDSLike Marrow Abnormalities: The Importance of Excluding Reversible Causes
Research Journal of Critical Care Nephrology · 19.10.2026 · 2 (04) · 301-306
DOI: 10.66224/rjccn.2.04.61 ↗Kurz gefasst
Fachartikel in der Zeitschrift Research Journal of Critical Care Nephrology, online erschienen am 19.10.2026. Verfasst von Yukinobu Ikegishi. Die Arbeit nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Erythropoiesis-stimulating agent (ESA) hyporesponsiveness in elderly patients undergoing maintenance hemodialysis is frequently multifactorial and may be difficult to distinguish from anemia associated with primary bone marrow disorders. Case Report. We report an 89-year-old man with ESA-resistant, transfusion-dependent anemia. Bone marrow examination demonstrated dysplastic megakaryocytic changes and isolated loss of the Y chromosome, raising concern for an underlying clonal marrow disorder. However, serum copper and ceruloplasmin levels showed no evidence of copper deficiency, and no zinc excess was identified. Hematologic improvement occurred during a period in which pneumonia and volume overload improved; however, luspatercept had previously been administered while ESA and intravenous iron therapy were continued, precluding attribution of the response to any single intervention.
Conclusions
This case highlights the importance of integrating MDS-like marrow findings with systematic and longitudinal assessment of potentially reversible contributors to ESA hyporesponsiveness, because marrow abnormalities and reversible causes of impaired erythropoiesis may coexist in elderly hemodialysis patients.
Zitieren
APA
Ikegishi, Y. (2026). Diagnostic Challenges of ESA-Resistant Anemia with MDSLike Marrow Abnormalities: The Importance of Excluding Reversible Causes. Research Journal of Critical Care Nephrology, 2(04), 301-306. https://doi.org/10.66224/rjccn.2.04.61
Vancouver
Ikegishi Y. Diagnostic Challenges of ESA-Resistant Anemia with MDSLike Marrow Abnormalities: The Importance of Excluding Reversible Causes. Research Journal of Critical Care Nephrology. 2026;2(04):301-306. doi:10.66224/rjccn.2.04.61
BibTeX
@article{Ikegishi2026,
author = {Ikegishi, Yukinobu},
title = {Diagnostic Challenges of ESA-Resistant Anemia with MDSLike Marrow Abnormalities: The Importance of Excluding Reversible Causes},
journal = {Research Journal of Critical Care Nephrology},
year = {2026},
volume = {2},
number = {04},
pages = {301--306},
doi = {10.66224/rjccn.2.04.61}
}
EUVIMED